BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1703610)

  • 1. Sulfhydryl group in angiotensin converting enzyme inhibitors and superoxide radical formation.
    Mehta JL; Nicolini FA; Lawson DL
    J Cardiovasc Pharmacol; 1990 Nov; 16(5):847-9. PubMed ID: 1703610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals?
    Westlin W; Mullane K
    Circulation; 1988 Jun; 77(6 Pt 2):I30-9. PubMed ID: 2836109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidant effects of angiotensin-converting enzyme (ACE) inhibitors: free radical and oxidant scavenging are sulfhydryl dependent, but lipid peroxidation is inhibited by both sulfhydryl- and nonsulfhydryl-containing ACE inhibitors.
    Chopra M; Beswick H; Clapperton M; Dargie HJ; Smith WE; McMurray J
    J Cardiovasc Pharmacol; 1992 Mar; 19(3):330-40. PubMed ID: 1378110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative free radical scavenging action of angiotensin-converting enzyme inhibitors with and without the sulfhydryl radical.
    Suzuki S; Sato H; Shimada H; Takashima N; Arakawa M
    Pharmacology; 1993 Jul; 47(1):61-5. PubMed ID: 8393194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin converting enzyme inhibitors as oxygen free radical scavengers.
    Mira ML; Silva MM; Queiroz MJ; Manso CF
    Free Radic Res Commun; 1993; 19(3):173-81. PubMed ID: 8244086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free radical scavenging: a potentially beneficial action of thiol-containing angiotensin converting enzyme inhibitors.
    Chopra M; McMurray J; Stewart J; Dargie HJ; Smith WE
    Biochem Soc Trans; 1990 Dec; 18(6):1184-5. PubMed ID: 2088853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Captopril and ramiprilat protect against free radical injury in isolated working rat hearts.
    Pi XJ; Chen X
    J Mol Cell Cardiol; 1989 Dec; 21(12):1261-71. PubMed ID: 2698963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free radical scavenging properties of alacepril metabolites and lisinopril.
    Noda Y; Mori A; Packer L
    Res Commun Mol Pathol Pharmacol; 1997 May; 96(2):125-36. PubMed ID: 9226747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of sulfhydryl-containing angiotensin converting enzyme inhibitors against free radical injury in endothelial cells.
    Mak IT; Freedman AM; Dickens BF; Weglicki WB
    Biochem Pharmacol; 1990 Nov; 40(9):2169-75. PubMed ID: 2173602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of .OH scavenging action by non-SH-containing angiotensin converting enzyme inhibitor imidaprilat using microdialysis.
    Obata T; Yamanaka Y
    J Physiol Paris; 1998 Feb; 92(1):1-4. PubMed ID: 9638590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative studies of angiotensin converting enzyme inhibitors with and without the SH-radical.
    Nakagawa M; Kobayashi K; Sawada S; Toyoda T; Shirai K; Katoh K; Yamamoto K; Tsuji H; Sasaki S; Takeda K
    Am J Hypertens; 1991 Jan; 4(1 Pt 2):54S-55S. PubMed ID: 1848988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of captopril and enalapril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE inhibitors in high dieted methionine mice.
    Liu YH; Liu LY; Wu JX; Chen SX; Sun YX
    J Cardiovasc Pharmacol; 2006 Jan; 47(1):82-8. PubMed ID: 16424790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does luminol chemiluminescence detect free radical scavengers?
    Clapperton M; McMurray J; Fisher AC; Dargie HJ
    Br J Clin Pharmacol; 1995 Jun; 39(6):688-91. PubMed ID: 7654490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superoxide dismutase activity of the captopril-iron complex.
    Jay D; Cuella A; Jay E
    Mol Cell Biochem; 1995 May; 146(1):45-7. PubMed ID: 7651376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Captopril and enalaprilat do not scavenge the superoxide anion.
    Kukreja RC; Kontos HA; Hess ML
    Am J Cardiol; 1990 May; 65(19):24I-27I. PubMed ID: 2159692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin converting enzyme inhibitors improve contractile function of stunned myocardium by different mechanisms of action.
    Przyklenk K; Kloner RA
    Am Heart J; 1991 May; 121(5):1319-30. PubMed ID: 1850188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of myocardial reperfusion injury by sulfhydryl-containing angiotensin converting enzyme inhibitors.
    Liu X; Engelman RM; Rousou JA; Cordis GA; Das DK
    Cardiovasc Drugs Ther; 1992 Aug; 6(4):437-43. PubMed ID: 1387799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of sulphydryl- and non-sulphydryl-containing ACE inhibitors on left ventricular relaxation in the isolated guinea pig heart.
    Anning PB; Grocott-Mason RM; Lewis MJ
    Endothelium; 1997; 5(4):265-75. PubMed ID: 9588818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between carnosine and captopril on free radical scavenging activity and angiotensin-converting enzyme activity in vitro.
    Nakagawa K; Ueno A; Nishikawa Y
    Yakugaku Zasshi; 2006 Jan; 126(1):37-42. PubMed ID: 16394648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.
    Grover GJ; Sleph PG; Dzwonczyk S; Wang P; Fung W; Tobias D; Cushman DW
    J Pharmacol Exp Ther; 1991 Jun; 257(3):919-29. PubMed ID: 1646329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.